targeted factor viii delivery in hemophilia with inhibitors
Published 7 years ago • 1.7K plays • Length 6:32Download video MP4
Download video MP3
Similar videos
-
2:27
the impact of hemophilia inhibitors on patient outcomes
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
1:17
emerging strategies to support patients with hemophilia a
-
1:23
the present and future of hemophilia a treatment
-
18:51
isth academy presentation: half-life extended factor viii for the treatment of hemophilia a
-
27:32
chapter 7: treatment of specific hemorrhages
-
45:34
stop the bleeding - an update on hemophilia treatment
-
2:08
an overview of ongoing clinical trials for the treatment of hemophilia
-
1:05
promising antibodies being explored in hemophilia & a novel diagnostic tool for patients
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
4:18
haven 6: emicizumab prophylaxis in non-severe hemophilia a without fviii inhibitors
-
9:36
hemophilia (year of the zebra)
-
1:43
the safety and efficacy of fitusiran prophylaxis in patients with hemophilia a and b
-
1:11
current treatment options for hemophilia a
-
3:29
fitusiran prophylaxis shows encouraging results in hemophilia patients
-
3:03
insights into the mechanism of action of fitusiran & the value of this agent in hemophilia treatment
-
1:06
overview of the diagnostic work-up for hemophilia
-
1:06
isth 2024 highlights: promising upcoming treatments for hemophilia
-
5:18
hope-b: etranacogene dezaparvovec in adult hemophilia b
-
1:48
the promise of fitusiran for the treatment of patients with hemophilia a and b
-
19:40
chromogenic factor viii and ix assays: impact on diagnosis and management of hemophilia